Dr. Martin Farlow, MD
Claim this profileIndiana University
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
More about Martin Farlow, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Martin Farlow, MD has experience with
- APT Webstudy
- None
- Pepinemab
- No Treatment
Breakdown of trials Martin Farlow, MD has run
Alzheimer's Disease
Mild Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martin Farlow, MD specialize in?
Martin Farlow, MD focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Martin Farlow, MD currently recruiting for clinical trials?
No, Martin Farlow, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Martin Farlow, MD has studied deeply?
Yes, Martin Farlow, MD has studied treatments such as APT Webstudy, None, Pepinemab.
What is the best way to schedule an appointment with Martin Farlow, MD?
Apply for one of the trials that Martin Farlow, MD is conducting.
What is the office address of Martin Farlow, MD?
The office of Martin Farlow, MD is located at: Indiana University, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.